Intratumoral microbiome in breast cancer: A hidden player in tumor development, progression and treatment response
Jacopo Canzian(Humanitas University), Rita De Sanctis(Humanitas University), Alberto Zambelli, A. Floreani(Humanitas University), Paola Tiberio(Fondazione IRCCS Istituto Nazionale dei Tumori), Flavia Jacobs(Fondazione IRCCS Istituto Nazionale dei Tumori), María Rescigno(Austrian Academy of Sciences), Chiara Pozzi(European Institute of Oncology), Armando Santoro(IRCCS Humanitas Research Hospital), Chiara Miggiano(Humanitas University)
Cited by 5
Related Papers
Metagenomic analysis of colorectal cancer datasets identifies cross-cohort microbial diagnostic signatures and a link with choline degradation
|Nature Medicine|2019|1.1k
Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trial
|Journal of Hepatology|2012|821
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer
|Annals of Oncology|2021|743
Dendritic Cell Survival and Maturation Are Regulated by Different Signaling Pathways
|The Journal of Experimental Medicine|1998|677